21268 ⎘
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient; Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
PROSTACYCLIN ANALOGUE FORMULATIONS
#602Oral gliptin compositions and method for preparation thereof
#603TREATMENT OF CUTANEOUS ADVERSE EFFECTS CAUSED BY ONCOLOGICAL THERAPY WITH TOPICAL TAPINAROF COMPOSITIONS
#604TRANSDERMAL COMPOSITIONS OF IBUPROFEN AND METHODS OF USE THEREOF
#605Anhydrous sodium thiosulfate and formulations thereof
#606Muscle Tissue-Regenerating Agent
#607Detection of a defect on HLA-E restricted CD8+ T regulatory cells
#608Method for treating type I diabetes with peptide-loaded dendritic cells
#609Method for treating multiple sclerosis with peptide-loaded dendritic cells
#610PREPARATION CONTAINING TETRACYCLIC COMPOUND AT HIGH DOSE
#611PHARMACEUTICAL PREPARATION COMPRISING AN AMIDE DERIVATIVE INHIBITING THE GROWTH OF CANCER CELL AND A PHARMACEUTICAL PRODUCT CONTAINING THE SAME
#612TOPICAL FORMULATIONS OF CYCLOOXYGENASE INHIBITORS AND THEIR USE
#613ANALGESIC COMPOSITIONS COMPRISING HALOGENATED VOLATILE COMPOUNDS
#614Penetrating topical pain relief compositions and methods of use
#615Therapeutic pharmaceutical compositions
#616NOVEL PHARMACEUTICAL FORMULATION
#617TOPICAL COMPOSITIONS COMPRISING A MACROLIDE IMMUNOSUPPRESSANT
#618Diabetic retinopathy treatment with stabilized dexamethasone
#619EXTERNAL PREPARATION FOR SKIN
#620Multifunctional Nanoparticles For Prevention And Treatment Of Atherosclerosis
#621NK CELL IMMUNOTHERAPY COMPOSITIONS, METHODS OF MAKING AND METHODS OF USING SAME
#622FORMULATIONS USING LITHIUM TO TREAT GOUT ARTHROPATHY
#623TRANSDERMAL MEDICAMENT
#624CAMPHORSULFONIC ACID AND COMBINATIONS THEREOF WITH CATIONIC EXCIPIENTS AS VISCOSITY REDUCING AGENTS IN HIGH CONCENTRATED PROTEIN FORMULATIONS
#625TREATMENT OF CARDIOVASCULAR DISEASES
#626DRUG DELIVERY FORMULATIONS
#627Anhydrous sodium thiosulfate and formulations thereof
#628FORMULATIONS OF BENDAMUSTINE
#629FORMULATIONS OF PSMA IMAGING AGENTS
#630INJECTABLE FORMULATION
#631COMPOSITIONS COMPRISING STREPTOCOCCUS PNEUMONIAE POLYSACCHARIDE-PROTEIN CONJUGATES AND METHODS OF USE THEREOF
#632CNP PRODRUGS WITH LARGE CARRIER MOIETIES
#633HIGHLY WATER-SOLUBLE SALTS OF A SHORT ACTING PHENYLALKYLAMINE CALCIUM CHANNEL BLOCKER AND USES THEREOF
#634Pharmaceutical compositions for delivery of peptide
#635Hydrocortisone acetate suppository formulation for treatment of disease
#636BUFFER SOLUTIONS FOR ELECTROPORATION
#637High concentration antibody-containing liquid formulation
#638COMPOSITIONS AND METHODS INVOLVING POLYMER, SOLVENT AND HIGH VISCOSITY LIQUID CARRIER MATERIAL
#639PHARMACEUTICAL FORMULATIONS COMPRISING DICLOFENAC
#640Phenyl containing compound, intermediate thereof, preparation method therefor and application thereof
#641SYSTEMS, COMPOSITIONS AND METHODS FOR TREATING DIABETES
#642IMPROVED FORMULATIONS FOR IMMUNE CELLS
#643TOPICAL FORMULATIONS FOR TREATMENT OF PERIPHERAL NEUROPATHIES
#644FORMULATIONS OF BENDAMUSTINE
#645FORMULATIONS OF GLUCAGON-LIKE-PEPTIDE-2 (GLP-2) ANALOGUES
#646Compositions and methods for modulating gene or gene product in cells
#647Nail hardening composition and method of use
#648USE OF INHIBITORS OF BRUTONS TYROSINE KINASE (BTK)
#649IMMEDIATE RELEASE PHARMACEUTICAL FORMULATION OF 4-[3-(4-CYCLOPROPANECARBONYL-PIPERAZINE-1-CARBONYL)-4-FLUORO-BENZYL]-2H-PHTHALAZIN-1-ONE
#650Non-lethal defensive fluid composition and pressurized delivery system
#651Formulations of PBMCs
#652Pharmaceutical composition and administrations thereof
#653SOLID COMPOSITIONS COMPRISING A GLUCOKINASE ACTIVATOR AND METHODS OF MAKING AND USING THE SAME
#654Antibody Compositions and Methods of Use Thereof
#655FORMULATIONS OF ACTIVATING ANTIGEN CARRIERS
#656EXOSOME SYSTEMS, PRODUCTS AND METHODS
#657Daptomycin Aqueous Formulations
#658IONIZABLE CATIONIC LIPIDS AND LIPID NANOPARTICLES, AND METHODS OF SYNTHESIS AND USE THEREOF
#659Exosome systems, products and methods
#660A STABLE FORMULATION OF ARYLSULFONYLPROPENENITRILES
#661COMPOSITIONS AND METHODS FOR TREATING NAIL INFECTIONS
#662Nail hardening composition and method of use
#663Production of Biosimilar Ustekinumab In CHO Cells
#664BIODEGRADABLE DRUG DELIVERY COMPOSITIONS
#665FORMULATIONS OF A COMPOUND MODULATING KINASES
#666Methods for treating ciliated cavities
#667METHOD FOR PRODUCING RADIOPHARMACEUTICAL AND RADIOPHARMACEUTICAL
#668LIQUID PHARMACEUTICAL COMPOSITION
#669STABLE FORMULATIONS OF CYCLIC DINUCLEOTIDE STING AGONIST COMPOUNDS AND METHODS OF USE THEREOF
#670USE OF INHIBITORS OF BRUTONS TYROSINE KINASE (BTK)
#671COMBINATION OF CHIR99021 AND VALPROIC ACID FOR TREATING HEARING LOSS
#672COMPOSITIONS FOR RETARDING THE DECOMPOSITION OF MELATONIN IN SOLUTION
#673Method for treating melanoma
#674PREPARATION OF SOLUBLE FORM OF CURCUMIN
#675ANHYDROUS SODIUM THIOSULFATE AND FORMULATIONS THEREOF
#676METHODS OF TREATMENT AND PHARMACEUTICAL COMPOSITIONS USING BCN057 OR BCN512
#677Oral liquid composition comprising ivacaftor
#678Compositions and kits useful for treatment of respiratory illness
#679Composition and method for proton pump inhibitor suspension
#680Oral compositions for post-dental implants
#681Combination of antibody-drug conjugate and immune checkpoint inhibitor
#682Soft Chewable Pharmaceutical Products
#683TRANSDERMAL PATCH
#684PHARMACEUTICAL COMPOSITION COMPRISING A GLP-1 AGONIST, AN INSULIN AND METHIONINE
#685Aqueous compositions of bortezomib
#686METHODS FOR TREATING VITILIGO LESIONS HAVING IMPROVED EFFICACY
#687Biologically active ganoderma lucidum compounds and synthesis of anticancer derivatives; ergosterol peroxide probes for cellular localization
#688Compositions for preventing or treating viral and other microbial infections
#689BOTULINUM TOXIN-STABILIZING LIQUID COMPOSITION
#690COMPOSITION AND METHOD FOR COMPOUNDED THERAPY
#691ANTIBODY FORMULATIONS
#692Preparation of preliposomal Annamycin lyophilizate
#693PULLULAN EMPTY HARD CAPSULE AND PREPARATION METHOD THEREFOR
#694METHOD FOR IMPROVING STORAGE STABILITY
#695Medroxyprogesterone acetate injectable compositions and methods of use
#696Parenteral Pharmaceutical Composition Comprising Azacitidine or Decitabine in DMSO
#697AQUEOUS PHARMACEUTICAL FORMULATION OF HYDROCORTISONE SODIUM PHOSPHATE AND MONOTHIOGLYCEROL
#698Precipitation resistant small molecule drug formulations
#699RESIQUIMOD TOPICAL AND INJECTABLE COMPOSITIONS FOR THE TREATMENT OF NEOPLASTIC SKIN CONDITIONS
#700RETINAL PIGMENT EPITHELIUM CELL COMPOSITIONS
#701VISCOSITY REDUCTION OF HIGHLY CONCENTRATED PROTEIN FORMULATIONS
#702Use of tacrolimus in preparation of medicament for initiating tissue regeneration function
#703FORMULATIONS
#704NOVEL COMPOSITION
#705PHARMACEUTICAL FORMULATION
#706IMPLANTABLE DEVICES FOR TREATING HIV
#707FULVESTRANT FORMULATIONS
#708Methods of inhibiting pathological angiogenesis
#709Density flow meter for pharmaceutical formulation dosing
#710Stable Formulations Comprising A Bispecific EGFR/C-Met Antibody
#711Cannabinoid and menthol transdermal delivery systems and methods
#712Pharmaceutical compositions comprising Gd-complexes and polyarylene additives
#713EXCIPIENT COMPOUNDS FOR PROTEIN FORMULATIONS
#714PHARMACEUTICAL CARRIER FOR ACTIVE SUBSTANCES AND A PHARMACEUTICAL COMPOSITION CONTAINING SAID CARRIER
#715Methods of Treating Multiple Myeloma
#716Stabilised Compositions of Factor VII Polypeptides
#717TREATMENT OF PSORIASIS WITH TOPICAL TAPINAROF-TAZAROTENE COMBINATION COMPOSITIONS
#718Modifier system for compositions containing layered double hydroxide
#719Methods of making and using polyphenols complexed with a protein, peptide, amino acid, polysaccharide, disaccharide, or monosaccharide
#720Percutaneous absorption preparation comprising stabilized donepezil
#721Medroxyprogesterone acetate injectable compositions and methods of use
#722Compositions with permeation enhancers for drug delivery
#723Anti-IL-6 Antibody Formulation
#724FORMULATIONS OF PHOSPHOINOSITIDE 3-KINASE INHIBITORS
#725HIGHLY WATER-SOLUBLE SALTS OF A SHORT ACTING PHENYLALKYLAMINE CALCIUM CHANNEL BLOCKER AND USES THEREOF
#726PNEUMOCOCCAL CONJUGATE VACCINE FORMULATIONS
#727Formulations of phosphoramidate derivatives of nucleoside drugs
#728Formulation comprising a gemcitabine-prodrug
#729Laureth-4 containing topical formulations
#730Compositions for Broad Spectrum Topical Antimicrobials
#731Aqueous formulation comprising paracetamol and ibuprofen
#732IRINOTECAN LIPOSOME PREPARATION, AND PREPARATION AND APPLICATION THEREOF
#733Lipids and compositions for the delivery of therapeutics
#734ISOPROPYLCARBONATE BENZOYL PEROXIDE COMPOSITIONS AND METHODS OF USE
#735Compositions and kits useful for treatment of respiratory illness
#736NANOCRYSTALLINE EYE DROP, PREPARATION METHOD AND USE THEREOF
#737PEPTIDE HYDROGELS FOR DELIVERY OF IMMUNOSUPPRESSIVE DRUGS AND USES THEREOF
#738Branched amino acid surfactants for use in healthcare products
#739PREMIXED, READY TO USE PHARMACEUTICAL COMPOSITIONS OF AMIODARONE
#740Preparation Stabilized by Means of Nonaqueous Solvent
#741EPINEPHRINE PARENTERAL FORMULATIONS
#742LYOPHILIZED PHARMACEUTICAL COMPOSITIONS
#743Trace element compositions, methods of making and use
#744PHARMACEUTICAL BIODISSOLVABLE GELS FOR DRUG DELIVERY
#745MOUTHWASH/GARGLE, NASAL/ORAL/NASAL SPRAY COVID AND BACTERIOCIDE ARRANGEMENT
#746Sublingual Epinephrine Compositions Including pH-Modifying Excipients And Penetration Enhancers And Methods for Use Thereof
#747TRANS-RESVERATROL TOPICAL MEDICATION FOR THE TREATMENT OF PAIN AND METHOD OF MANUFACTURE THEREOF
#748Stable sustained release therapeutic compositions in aprotic polar solvents and methods of manufacturing the same
#749Compositions for the treatment of , acne and joint pain
#750Therapeutic pharmaceutical compositions
#751Multi-functional hemocompatible porous polymer bead sorbent for removing protein based toxins and potassium from biological fluids
#752Nanoparticles carrying antibiotics
#753SKIN CRÈME
#754DERMAL PATCHES AND GLASS SWABS FOR APPLICATION OF TOPICAL IMMUNOSENSITIZERS
#755FORMULATIONS OF BENDAMUSTINE
#756DERMAL PATCHES AND GLASS SWABS FOR APPLICATION OF TOPICAL IMMUNOSENSITIZERS
#757BODY FLUID EXPANDERS COMPRISING N-SUBSTITUTED AMINOSULFONIC ACID BUFFERS
#758RAPID ACTION INSULIN FORMULATIONS AND PHARMACEUTICAL DELIVERY SYSTEMS
#759NANOEMULSION SYSTEM FOR TRANSDERMAL DELIVERY OF PHARMACEUTICAL COMPOSITIONS AND OTHER ACTIVE AGENTS
#760EXCIPIENT COMPOUNDS FOR PROTEIN PROCESSING
#761Pharmaceutical liquid composition of botulinum toxin with improved stability
#762New Ammonium Salts Of Fluorinated Organic Acids, Method Of Their Synthesis and Application
#763Composition for improving bioavailability of drugs
#764Pharmaceutical formulation
#765METHODS FOR USING ANTIMICROBIAL COMPOSITIONS
#766PHARMACEUTICAL COMPOSITIONS AND DOSAGE REGIMENS CONTAINING ANTI-ALPHA(V)BETA(6) ANTIBODIES
#767Pharmaceutical compositions of sulfur colloid and processes thereof
#768CRYSTALLINE PRODUCT
#769EPINEPHRINE SPRAY FORMULATIONS
#770Epinephrine spray formulations
#771Ionic liquid-based nanoemulsion formulation for the efficient delivery of hydrophilic and hydrophobic therapeutic agents
#772Subcutaneous anti-HER2 Antibody Formulations and Uses Thereof
#773Hypoglycemic pharmaceutical composition
#774Compositions and methods comprising growth factors, chondroitin and glucosamine for degenerative disc regeneration
#775APREMILAST PHARMACEUTICAL COMPOSITIONS AND METHODS
#776STABLE AQUEOUS INJECTABLE SOLUTION OF EPINEPHRINE
#777Methods of using nitric oxide donor compounds for treatment of COVID-19 and other infectious diseases
#778EPINEPHRINE SPRAY FORMULATIONS
#779METHOD OF ADMINISTERING LOCAL ANESTHETIC SOLUTION FOR DENTAL AND/OR CONTRAST MEDIA USE
#780PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF COVID-19
#781Pharmaceutical compositions of tofacitinib for oral administration
#782Clobazam transdermal delivery system and uses thereof
#783Method for preparing a composition with a low dissolved oxygen content, comprising acetaminophen, and optionally one or more NSAIDs, and a composition obtained thereof
#784LONG-ACTING POLYMERIC DELIVERY SYSTEMS
#785TOPICAL COMPOSITION OF NALBUPHINE AND METHOD FOR TREATING PRURITUS CONDITION, PAIN, OR INFLAMMATORY CONDITION BY USING THE SAME
#786ORAL SOLID FORMULATION CONTAINING IRINOTECAN AND METHOD OF PREPARING THE SAME
#787Compositions Comprising Antioxidant, Fluid Dispensers, and Methods Involving the Same
#788Compositions for use to treat advanced glycation end products-dependent ocular diseases
#789COMPOSITIONS WITH SYNERGISTIC PERMEATION ENHANCERS FOR DRUG DELIVERY
#790COMPOSITIONS COMPRISING CBD FOR TREATING DERMATOLOGICAL CONDITIONS
#791FORMULATIONS FOR IMPROVED STABILITY OF RECOMBINANT HUMAN PARATHYROID HORMONE
#792STABLE FORMULATIONS FOR PARENTERAL INJECTION OF PEPTIDE DRUGS
#793Compositions and methods for degenerative disc regeneration
#794HYDROGEL COMPOSITION AND HYDROGEL LENS
#795SUSTAINED-RELEASE INJECTABLE ANTIBIOTICAL FORMULATION
#796Film dosage form with extended release mucoadhesive particles
#797Niclosamide formulations and methods of use
#798Injectable buprenorphine formulation
#799THERAPEUTICALLY ACTIVE ALDESLEUKIN HIGHLY STABLE IN LIQUID PHARMACEUTICAL COMPOSITIONS
#800STABLE IODINE-CONTAINING ANTIMICROBIAL TEAT DIP COMPOSITIONS
#801Use of a virucidal preparation in the nasal cavity for prevention of transmission or contraction of viral illnesses, or to shorten the duration of, or lessen the severity of viral illnesses.
#802SURFACTANTS FOR HEALTHCARE PRODUCTS
#803Coronavirus vaccine compositions and methods
#804Compositions and methods for inducing immune responses
#805Botanical formulations
#806Artificial compositions comprising corosolic acid, oleanolic acid; and ursolic acid in a form of an emulsion, salve, ointment, suspension, or gel
#807LIQUID FORMULATIONS OF GLUCAGON ANALOGUES
#808ExPEC glycoconjugate vaccine formulations
#809USE OF A CREAM THAT PROTECTS AGAINST THE EFFECTS OF AGGRESSIVE CHEMICAL AGENTS IN CONTACT WITH THE SKIN
#810Neoantigens and uses thereof
#811Pharmaceutical aqueous formulation comprising 1-(4-{[4-(dimethylamino)piperidin-1-yl]carbonyl}phenyl)-3-[4-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)phenyl]urea
#812CANNABINOID ORAL DISPERSIBLE FILM STRIP
#813Liquid Pharmaceutical Composition Comprising an Anti-IL-6 Receptor Antibody
#814FULVESTRANT FORMULATIONS
#815Nanometric pharmaceutical composition in the form of liposomes or nanoemulsion containing specific sequences of interference RNA
#816PROCESS FOR PRODUCING A T CELL COMPOSITION
#817IONIZABLE CATIONIC LIPID FOR RNA DELIVERY
#818Multicomponent degradable cationic polymers
#819Methods for providing a homogenous solution of lyophilized mutant diptheria toxin in dimethylsulfoxide
#820COMPOSITIONS AND METHODS FOR STORAGE STABLE OPHTHALMIC DRUGS
#821Topical composition and delivery system and its use
#822Patch with DMSO in adhesive layer
#823Ready to use liquid formulation
#824ORAL MUCOSAL DELIVERY SYSTEMS COMPRISING MONOPHASIC CONCENTRATE OF TERIPARATIDE
#825High concentration antibody-containing liquid formulation
#826Method to prepare therapeutically active aldesleukin highly stable in liquid pharmaceutical compositions
#827Treatment of vomiting and nausea with minimum dose of olanzapine
#828Method for the cryopreservation of cells for therapeutic purposes
#829IODOPHOR COMPOSITION WITH IMPROVED STABILITY IN THE PRESENCE OF ORGANIC MATERIAL
#830Oral care compositions
#831Composition comprising a mixture of an extract and bentonite
#832Methods and compositions for treating cancer
#833New Medical Devices, Delivery Vehicles and Manufacturing Thereof
#834Long-acting polymeric delivery systems
#835Veterinary compositions and the uses thereof for controlling iron deficiencies in non-human mammals
#836Compounded compositions and methods for treating pain
#837Method for manufacturing acetaminophen preparation
#838BIPHASIX CANNABINOID DELIVERY
#839Compositions and methods for controlled release of target agent
#840TOPICAL COMPOSITIONS FOR STIMULATING HAIR GROWTH
#841Compositions and methods for reducing laminitis of an animal hoof
#842Econazole nitrate medical patch and methods of use thereof
#843Topical formulations comprising tofacitinib
#844CSF-1R ANTIBODY FORMULATION
#845Compositions and methods for treatment of amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases, and associated methods for preparing said compositions
#846HIGHLY WATER-SOLUBLE SALTS OF A SHORT ACTING PHENYLALKYLAMINE CALCIUM CHANNEL BLOCKER AND USES THEREOF
#847FORMULATION OF NANOSTRUCTURED GELS FOR INCREASED AGENT LOADING AND ADHESION
#848Stable pharmaceutical formulations of pemetrexed
#849Materials and methods for improving gastrointestinal function
#850Pharmaceutical compositions containing anti-beta amyloid antibodies
#851Cleavable conjugates of catechol compounds and water-soluble polymers and methods of treatment using the same
#852Topical immunosensitizers to treat viral and fungal infections
#853Nitric oxide generating systems for inhalation
#854CNP prodrugs with large carrier moieties
#855EXTENDED RELEASE FORMULATIONS FOR INTRA-ARTICULAR APPLICATIONS
#856Solid oral pharmaceutical compositions for isoxazoline compounds
#857OPHTHALMIC SOLUTION OF ANTIOXIDANT
#858Antimicrobial peptide stimulating cleansing composition
#859PHARMACEUTICAL COMPOSITIONS AND METHODS
#860Use of inhibitors of Brutons tyrosine kinase (Btk)
#861RINSE-OFF COMPOSITIONS AND USES THEREOF FOR DELIVERY OF ACTIVE AGENTS
#862Bendamustine solution formulations
#863NOVEL LIPIDS AND COMPOSITIONS FOR THE DELIVERY OF THERAPEUTICS
#864Excipient compounds for biopolymer formulations
#865BIODEGRADABLE DRUG DELIVERY COMPOSITIONS
#866Ophthalmic Formulations and Uses Thereof
#867WATER SOLUBLE FORMULATION FOR PHARMACEUTICAL AND NUTRACEUTICAL COMPOUNDS AND METHOD OF PREPARING THEREOF
#868Purified pentagalloyl glucose and devices for delivery
#869Stable Liquid Compositions of Melphalan
#870Inhalable liposomal sustained release composition for use in treating pulmonary diseases
#871PHARMACEUTICAL FORMULATIONS, METHOD FOR PRODUCING A PHARMACEUTICAL FORMULATION, AND MEDICAMENT COMPRISING SAME
#872PROLACTIN RECEPTOR ANTIBODY FOR MALE AND FEMALE PATTERN HAIR LOSS
#873Compositions and methods of use of cis-4-[2-{[(3S,4R)-3-fluorooxan-4-yl]amino}-8-(2,4,6-trichloroanilino)-9H-purin-9-yl]-1- methylcyclohexane-1-carboxamide
#874Pharmaceutical compositions of IL-2
#875Interactional Biosystem
#876Group B adenovirus-containing formulation
#877Safe and Effective Method of Treating Ulcerative Colitis with Anti-IL12/IL23 Antibody
#878IMPROVED METHODS OF MANUFACTURING PEPTIDE-BASED VACCINES
#879EXCIPIENT COMPOUNDS FOR PROTEIN FORMULATIONS
#880METHODS FOR TREATING CONGENITAL EPIDERMAL HYPERPLASIA AND COMPOSITIONS FOR SAME
#881LIQUID FORMULATIONS OF BENDAMUSTINE
#882Subcutaneous formulations of anti-CD38 antibodies and their uses
#883PHARMACEUTICAL FORMULATION OF CROTONYLAMINOPYRIDINE SALT
#884FORMULATIONS OF BENDAMUSTINE
#885Method of treating a skin wound with a liquid-state topical pharmaceutical composition
#88617-hydroxyprogesterone ester-containing oral compositions and related methods
#887Systems for aneurysm treatment
#888Pharmaceutical composition of pemetrexed
#889Subcutaneous formulations of anti-CD38 antibodies and their uses
#890Sincalide Formulations
#891Epinephrine spray formulations
#892TRANSDUCTION BUFFER
#893Liquid Protein Formulations Containing Viscosity-Lowering Agents
#894NOVEL COMPOSITION
#895FORMULATIONS COMPRISING CHELATORS, PERMEATION ENHANCERS AND HYDROXYETHYL CELLULOSE FOR TREATING OPHTHALMIC DISORDERS
#896Stable pharmaceutical compositions of dihydroergotamine mesylate
#897Formulation
#898Injectable pharmaceutical formulation
#899SUBCUTANEOUS HER2 ANTIBODY FORMULATIONS
#900CNP PRODRUGS WITH LARGE CARRIER MOIETIES